NCT04926142View on ClinicalTrials.gov

Prevalence of Atrial Fibrillation in Cryptogenic Stroke With Patent Foramen Ovale Closure (PFO-AF) Study

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

July 5, 2021

Primary Completion Date

August 21, 2025

Study Completion Date

December 31, 2025

Conditions
Patent Foramen OvaleAtrial FibrillationStroke
Interventions
DEVICE

Implantation of Holter device

Implantation of a Holter device (Reveal Linq, Medtronic) for telemonitoring of cardiac rhythm

PROCEDURE

Percutaneous PFO closure

Patients will undergo percutaneous closure of patent foramen ovale

Trial Locations (4)

25000

University Hospital Besancon, Besançon

Unknown

CHU Lyon - Hôpital Louis Pradel, Bron

CHU Dijon, Dijon

CHU Grenoble, Grenoble

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER